Navigation Links
Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide
Date:11/9/2009

d syncope were observed in clinical trials. Use INTUNIV with caution in treating patients who have experienced hypotension, bradycardia, heart block, or syncope, or who may have a condition that predisposes them to syncope; are treated concomitantly with antihypertensives or other drugs that can reduce blood pressure or heart rate or increase the risk of syncope. Heart rate and blood pressure should be measured prior to initiation of therapy, following dose increases, and periodically while on therapy. Patients should be advised to avoid becoming dehydrated or overheated.

Sedation and somnolence were commonly observed in clinical trials. The potential for additive sedative effects with CNS depressant drugs should be considered. Patients should be cautioned against operating heavy equipment or driving until they know how they respond to INTUNIV. Avoid use with alcohol.

Common adverse reactions in patients taking INTUNIV that may be dose related over the range of 1 to 4 mg/day include somnolence, sedation, abdominal pain, dizziness, hypotension/decreased blood pressure, dry mouth, and constipation.

About ADHD

ADHD is one of the most common psychiatric disorders in children and adolescents. Worldwide prevalence of ADHD is estimated at 5.3 percent (with large variability), according to a comprehensive systematic review of this topic published in 2007 in the American Journal of Psychiatry. In the United States, approximately 7.8 percent of all school-aged children, or about 4.4 million children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the Centers for Disease Control and Prevention (CDC).

ADHD is a psychiatric behavioral disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of development. The specific etiolog
'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
2. New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners ADHD Rating Scale
3. Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
4. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
5. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
6. Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
7. New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting
8. New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation
9. ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%
10. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
11. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Ill. , May 17, 2013  Sony Biotechnology ... Sony SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting ... which will be held at the San ... Diego, California , from May 20 - 22.  ... second analytical system, incorporating commercial audio-visual technologies into new ...
(Date:5/17/2013)... -- TechAtlas Group has announced the release of the ... the Chronic Kidney Disease (CKD) market. This particular ... and devices currently on the market and in ... (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... denervation , diabetic nephropathy - antifibrotics ...
(Date:5/17/2013)... Puerto Rico , May 17, 2013  Serving a ... Puerto Rico , Caribbean Imaging and Radiation Therapy ... its radiation therapy capabilities with the acquisition of an Elekta ... . Versa HD offers clinicians the versatility to deliver ... the body, while also enabling treatment of highly complex cancers ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... 9, 2011 Vermillion, Inc. (NASDAQ: VRML ), ... third quarter ended September 30, 2011. Q3 ... tests during the third quarter, up 5% from the previous ... use clinical study of the company,s peripheral artery disease (PAD) ...
... 9, 2011 Emmy®-nominated actress Christina Hendricks, in partnership with ... LATISSE® (bimatoprost ophthalmic solution) 0.03% is calling on women to ... the Make-A-Wish Foundation by November 30 through the LATISSE® ... the tradition of blowing on an eyelash to make wishes ...
Cached Medicine Technology:Vermillion Reports Results for Third Quarter 2011 2Vermillion Reports Results for Third Quarter 2011 3Vermillion Reports Results for Third Quarter 2011 4Vermillion Reports Results for Third Quarter 2011 5Vermillion Reports Results for Third Quarter 2011 6Vermillion Reports Results for Third Quarter 2011 7Actress Christina Hendricks Urges Women to Join Her in the Final Weeks of the LATISSE® Wishes Challenge to Increase Money Raised for the Make-A-Wish Foundation® from $390,000 to Campaign Goal of $500,000 2Actress Christina Hendricks Urges Women to Join Her in the Final Weeks of the LATISSE® Wishes Challenge to Increase Money Raised for the Make-A-Wish Foundation® from $390,000 to Campaign Goal of $500,000 3Actress Christina Hendricks Urges Women to Join Her in the Final Weeks of the LATISSE® Wishes Challenge to Increase Money Raised for the Make-A-Wish Foundation® from $390,000 to Campaign Goal of $500,000 4Actress Christina Hendricks Urges Women to Join Her in the Final Weeks of the LATISSE® Wishes Challenge to Increase Money Raised for the Make-A-Wish Foundation® from $390,000 to Campaign Goal of $500,000 5Actress Christina Hendricks Urges Women to Join Her in the Final Weeks of the LATISSE® Wishes Challenge to Increase Money Raised for the Make-A-Wish Foundation® from $390,000 to Campaign Goal of $500,000 6
(Date:5/19/2013)... (PRWEB) May 19, 2013 Passages Malibu, ... treatment center, has announced this week the launch of ... the brands’ social media channels. “We are always ... treatment community and to get feedback regarding sobriety, what’s ... CEO and co-founder of the Passages Addiction Treatment ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The AMTC team ... at the Columbus Georgia Convention & Trade Center on June ... to attend. AMTC auditions are free of charge. , Actors, ... point for hundreds of successful artists and grads like Caitlin ... for European Tombolini , Chris Young - on his Liquid ...
(Date:5/19/2013)... 2013 The legal team at Pulaski ... a concerted effort to connect women and families coping ... drugs Yaz, Yasmin & Ocella with the legal representation ... on the notorious birth control drugs as well as ... , Yaz, Yasmin & Ocella were very popular birth ...
(Date:5/18/2013)... 2013 In “Cooking with Spirits for the ... author Janet Hall Svisdahl’s new cookbook, readers are transported into ... make even the pickiest eater drool. “I dedicate this book ... explains. , Found within the 364 pages of “Cooking ... delicious recipes, from fast and simple to gourmet. Each recipe ...
(Date:5/18/2013)... Orlando, FL (May 19, 2013) Each year, ... for their outstanding contributions and achievements in gastroenterology ... comprised of many distinguished and talented individuals who ... of gastroenterology. Today, we are pleased to announce ... acknowledged by their colleagues for their tremendous contributions ...
Breaking Medicine News(10 mins):Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5
... ... rugged tablet PCs, rugged UMPCs (Ultra Mobile PCs), rugged PDAs, and rugged handheld computers now ... been added to Group Mobile,s product line, with other rugged Unitech mobile computing devices to ... (PRWEB) ...
... ... to Work” list. LeBootCamp.com - the #1 French diet online - ranked No. ... environment and work ethics. , ... San Francisco (PRWEB) April 22, 2010 -- LeBootCamp.com today was named to ...
... ... ... from Florida and sleep in a tent because they cannot afford a hotel room; a ... cross country; and a couple who lives in rural Broxburn West Louthian Scotland will, for the ...
... , ... over 40 industry executives and leaders. This press release summarizes several of the many content-rich ... ... recently published over 40 video interviews with Health IT industry executives at HIMSS10 in Atlanta, ...
... safety enforcement helped end 11 years of increases , THURSDAY, ... the United States dropped by at least 10 percent in ... new report by the Governors Highway Safety Association. , Using ... report projected 4,762 motorcyclist deaths in 2009, compared ...
... for those with chronic illness or disability , THURSDAY, April ... ever-changing security rules when traveling can be tough for anyone, ... vials of insulin or someone who,s had a hip or ... , But Ann Davis, a spokeswoman for the U.S. ...
Cached Medicine News:Health News:Group Mobile adds Unitech Rugged Handheld Computers to its Product Offerings 2Health News:Group Mobile adds Unitech Rugged Handheld Computers to its Product Offerings 3Health News:Outside Magazine Names LeBootCamp as One of America's Best Places to Work in 2010 2Health News:Congresswoman Carolyn B. Maloney (NY) will deliver Keynote Address at Hysterectomy Conference 2Health News:EHRtv.com Publishes Over 40 Video Interviews from HIMSS10 2Health News:EHRtv.com Publishes Over 40 Video Interviews from HIMSS10 3Health News:Motorcycle Fatalities Drop Sharply in U.S. 2Health News:Flying With Needles and Meds Can Raise Security Flags 2Health News:Flying With Needles and Meds Can Raise Security Flags 3
... increase in Endoscopic cases, it is extremely popular ... the Surgical Light. This combination affords the ... to adopt an uncomfortable pose. The Single ... NUVO Monitoring System. As such the light ...
... offers all the performance of a major surgical ... use in Outpatient Settings, Minor Procedure Rooms, C-Section, ... single lights either side of the OR table ... General OR when combining Flat Screen LCD Monitors ...
... for outstanding performance, the SYSTEM ONE ... the most requested features: High output ... size, electronic touch controls for on/off ... suspension arm for maximum coverage, reserve ...
For the screening and detection by indirect immunofluorescence (IF) of primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
Medicine Products: